Bath & Body Works (NYSE:BBWI) Trading 4.8% Higher – Here’s What Happened

Bath & Body Works, Inc. (NYSE:BBWI)’s stock price rose 4.8% during trading on Friday . The stock traded as high as $19.70 and last traded at $19.55. 685,970 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 5,757,172 shares. The stock had previously closed at $18.65.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. TD Cowen lifted their price objective on shares of Bath & Body Works from $20.00 to $25.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Wells Fargo & Company dropped their price target on shares of Bath & Body Works from $26.00 to $24.00 and set an “overweight” rating on the stock in a research report on Thursday. Morgan Stanley decreased their price objective on shares of Bath & Body Works from $22.00 to $20.00 and set an “equal weight” rating for the company in a research report on Thursday. Raymond James Financial reaffirmed a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Finally, The Goldman Sachs Group cut Bath & Body Works from a “neutral” rating to a “sell” rating and reduced their price target for the stock from $23.00 to $19.00 in a report on Wednesday, July 8th. Four analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Bath & Body Works presently has an average rating of “Hold” and a consensus target price of $22.29.

Bath & Body Works Stock Performance

The stock’s fifty day simple moving average is $20.32 and its 200-day simple moving average is $19.97. The stock has a market cap of $3.91 billion, a P/E ratio of 5.06, a P/E/G ratio of 1.84 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.38. The business had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.50 billion. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%.The firm’s quarterly revenue was down 2.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.30 earnings per share. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, equities research analysts forecast that Bath & Body Works, Inc. will post 2.67 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 4.1%. The ex-dividend date of this dividend is Friday, August 21st. Bath & Body Works’s dividend payout ratio (DPR) is currently 20.83%.

Hedge Funds Weigh In On Bath & Body Works

Several hedge funds and other institutional investors have recently modified their holdings of BBWI. Global Retirement Partners LLC bought a new stake in shares of Bath & Body Works during the 4th quarter valued at approximately $31,000. Activest Wealth Management bought a new position in Bath & Body Works in the 4th quarter valued at approximately $32,000. Geneos Wealth Management Inc. lifted its stake in Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the last quarter. Parallel Advisors LLC boosted its position in Bath & Body Works by 42.6% in the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after buying an additional 567 shares in the last quarter. Finally, Danske Bank A S acquired a new stake in Bath & Body Works in the third quarter valued at approximately $39,000. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.